The orphan nuclear receptor known as estrogen-related receptor a (ERRa, NR3B1) and the peroxisome proliferator-activated receptor g co-activator 1a (PGC-1a) act together as a transcriptional regulatory node important for the expression of metabolic. Indeed, the PGC-1a/ERRa axis is now well established as a central regulator of energy metabolism that induces the global expression of genes involved in mitochondrial biogenesis and functions. Specifically, gene expression and genome-wide binding analyses demonstrated that PGC-1a and ERRa share a functional relationship in controlling the expression of vast metabolic gene networks in numerous tissues.
ERRa binds to the promoters of all genes encoding enzymes of glycolysis and many nuclear-encoded mitochondrial genes involved in energy. Moreover, PGC-1a and ERRa exploit auto-regulatory feedforward loops to promote the expression of metabolic genes and mitochondrial activity. The expression and activity of ERRa and PGC-1a are highly adaptable and can respond to various physiological and pathological cues.
In support of this point, PGC-1a is a key effector of the energy-sensing signaling cascade orchestrated by AMPactivated protein kinase (AMPK). AMPK occupies a central position in the reprogramming of cells to adapt to metabolic stress by promoting catabolism and inhibiting anabolism in order to restore the pool of cellular ATP.
Specifically, AMPK promotes catabolic reactions, such as lipid oxidation and cellular respiration, and inhibits anabolic processes, such as lipid and protein synthesis. AMPK activation induces the expression of PGC-1a, and the AMPK-mediated increase in mitochondrial respiration has been shown to be dependent on PGC-1a in muscle cells. In addition, AMPK phosphorylates PGC-1a, which potentiates its activity.
The PGC-1a/ERRa axis is a central regulator of metabolism in cancer, notably breast cancer. The expression of PGC-1a is reduced in breast tumors compared with normal tissues. However, within the various breast cancer subtypes, the levels of PGC-1a, along with that of ERRa, are highest in HER2+ and triple-negative breast tumors, the two breast cancer subtypes associated with the poorest prognosis.
Functional studies have shown that PGC-1a promotes the growth of HER2+ tumors by regulating intra-tumoral nutrient availability. ERRa also promotes the growth of HER2+ breast tumors by promoting the expression of the HER2 amplicon, and the ERRa signaling axis is downstream of HER2. In addition, a recent study has shown that the PGC-1a/ERRa axis is a positive regulator of glutamine metabolism in HER2+ breast tumors and that elevated expression of glutamine enzymes is associated with poor clinical outcome in breast cancer patients.
Reprogramming of cellular metabolism plays a central role in fueling malignant transformation, and AMPK and the PGC-1α/ERRα axis are key regulators of this process.
The intersection of gene-expression and binding-event datasets for breast cancer cells shows that activation of AMPK significantly increases the expression of PGC-1α/ERRα and promotes the binding of ERRα to its cognate sites.
Unexpectedly, the data also reveal that ERRα, in concert with PGC-1α, negatively regulates the expression of several one-carbon metabolism genes, resulting in substantial perturbations in purine biosynthesis.
This PGC-1α/ERRα-mediated repression of one-carbon metabolism promotes the sensitivity of breast cancer cells and tumors to the anti-folate drug methotrexate.
These data implicate the PGC-1α/ERRα axis as a core regulatory node of folate cycle metabolism and further suggest that activators of AMPK could be used to modulate this pathway in cancer.
http://www.cell.com/cell-reports/abstract/S2211-1247(15)01542-9
Edited
Latest News
Hyperactive platelets from…
By newseditor
Posted 19 May
Chromatin and RNA interacti…
By newseditor
Posted 18 May
Why patients with ARID1A mu…
By newseditor
Posted 18 May
Smuggling small molecule mo…
By newseditor
Posted 18 May
Men with gene mutations are…
By newseditor
Posted 17 May
Other Top Stories
Drumming improves behavior and brain function in autistic adolescents
Read more
How the brain controls symptoms of sickness
Read more
A novel membraneless organelle routes cell debris to proteasome dur…
Read more
A brain circuit for addiction remission
Read more
Estimating tumor-specific total mRNA level predicts cancer outcomes
Read more
Protocols
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Publications
An age-progressive platelet…
By newseditor
Posted 19 May
Immunotherapy for colorecta…
By newseditor
Posted 18 May
Single-cell multiplex chrom…
By newseditor
Posted 18 May
Autophagy preferentially de…
By newseditor
Posted 18 May
Poison Ivy, Poison Oak, and…
By newseditor
Posted 18 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar